Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

23 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
SARS-CoV-2 infection in children with cystic fibrosis: A cross-sectional multicenter study in Spain. New waves, new knowledge.
Mondejar-Lopez P, Moreno-Galarraga L, de Manuel-Gomez C, Blitz-Castro E, Bravo-Lopez M, Gartner S, Perez-Ruiz E, Caro-Aguilera P, Sanz-Santiago V, Lopez-Neyra A, Luna-Paredes C, Garcia-Gonzalez M, Costa-Colomer J, Cols-Roig M, Delgado-Pecellin I, Castillo-Corullon S, Ruiz de Valbuena-Maiz M, Garcia-Marcos PW, Aguilar-Fernandez AJ, Martin-De Vicente C, Barajas-Sanchez MV, Mesa-Medina O, Bover-Bauza C, Figuerola-Mulet J, Garcia-Aviles B, Rodriguez-Saez MJ, Garcia-Magan C, Juarez-Marruecos P, Gutierrez-Martinez JR, Cortell-Aznar I, Gomez-Pastrana D, Velasco-Gonzalez MV, Barrio MI, Sanchez-Solis M, Asensio de la Cruz O, Pastor-Vivero MD. Mondejar-Lopez P, et al. Among authors: lopez neyra a. Pediatr Pulmonol. 2023 Nov;58(11):3195-3205. doi: 10.1002/ppul.26644. Epub 2023 Aug 17. Pediatr Pulmonol. 2023. PMID: 37589420
[Spirometry patterns in vocal cord dysfunction].
Sanz Santiago V, López Neyra A, Almería Gil E, Villa Asensi JR. Sanz Santiago V, et al. An Pediatr (Barc). 2013 Mar;78(3):173-7. doi: 10.1016/j.anpedi.2012.07.001. Epub 2012 Aug 11. An Pediatr (Barc). 2013. PMID: 22884525 Free article. Spanish.
Compassionate Use of Lumacaftor/Ivacaftor in Cystic Fibrosis: Spanish Experience.
Diab-Cáceres L, Girón-Moreno RM, Pastor-Sanz MT, Quintana-Gallego E, Delgado-Pecellín I, Blanco-Aparicio M, Maiz L, García-Clemente MM, Luna-Paredes C, Mondéjar-López P, Ruiz-de-Valbuena M, Fernández O, Barrio M, González M, López-Neyra A, Cols-I-Roig M, Palou-Rotger A, Gómez-de-Terreros-Caro FJ. Diab-Cáceres L, et al. Arch Bronconeumol (Engl Ed). 2018 Dec;54(12):614-618. doi: 10.1016/j.arbres.2018.05.004. Epub 2018 Jul 7. Arch Bronconeumol (Engl Ed). 2018. PMID: 30518496 English, Spanish.
Impact of SARS-CoV-2 infection in patients with cystic fibrosis in Spain: Incidence and results of the national CF-COVID19-Spain survey.
Mondejar-Lopez P, Quintana-Gallego E, Giron-Moreno RM, Cortell-Aznar I, Ruiz de Valbuena-Maiz M, Diab-Caceres L, Prados-Sanchez C, Alvarez-Fernandez A, Garcia-Marcos PW, Peñalver-Mellado C, Pastor-Vivero MD, Olveira C, Lopez-Neyra A, Castillo-Corullon S, Palma-Milla S, Perez-Ruiz E, Sole-Jover A, Barrio MI, Sanchez-Solis M, Asensio de la Cruz Ó; CF-COVID19-Spain Registry Group. Mondejar-Lopez P, et al. Among authors: lopez neyra a. Respir Med. 2020 Aug-Sep;170:106062. doi: 10.1016/j.rmed.2020.106062. Epub 2020 Jun 8. Respir Med. 2020. PMID: 32843180 Free PMC article.
The global impact of SARS-CoV-2 in 181 people with cystic fibrosis.
McClenaghan E, Cosgriff R, Brownlee K, Ahern S, Burgel PR, Byrnes CA, Colombo C, Corvol H, Cheng SY, Daneau G, Elbert A, Faro A, Goss CH, Gulmans V, Gutierrez H, de Monestrol I, Jung A, Justus LN, Kashirskaya N, Marshall BC, McKone E, Middleton PG, Mondejar-Lopez P, Pastor-Vivero MD, Padoan R, Rizvi S, Ruseckaite R, Salvatore M, Stephenson AL, Filho LVRDS, Melo J, Zampoli M, Carr SB; Global Registry Harmonization Group. McClenaghan E, et al. J Cyst Fibros. 2020 Nov;19(6):868-871. doi: 10.1016/j.jcf.2020.10.003. Epub 2020 Nov 4. J Cyst Fibros. 2020. PMID: 33183965 Free PMC article.
Omalizumab outcomes for up to 6 years in pediatric patients with severe persistent allergic asthma.
Nieto García A, Garriga-Baraut T, Plaza Martín AM, Nieto Cid M, Torres Borrego J, Folqué Giménez MDM, Lozano Blasco J, Bosque García M, Moreno-Galarraga L, Tortajada-Girbés M, Rivas Juesas C, Penín Antón M, Caballero-Rabasco MA, Gaboli M, López Neyra A, Navarro Morón J, Freixa Benavente A, Valdesoiro Navarrete L, Ballester Asensio E, Sanz Santiago V, Romero García R, Gimeno Díaz de Atauri Á, Valenzuela Soria A, Sánchez Mateos M, Batlles Garrido J, Andrés Martín A, Campos Alonso E, Aragón Fernández C, Vázquez Rodríguez E, Martínez Pardo L, Del-Río Camacho G, Mazón Ramos Á. Nieto García A, et al. Among authors: lopez neyra a. Pediatr Allergy Immunol. 2021 Jul;32(5):980-991. doi: 10.1111/pai.13484. Epub 2021 Mar 20. Pediatr Allergy Immunol. 2021. PMID: 33619748
Factors associated with clinical progression to severe COVID-19 in people with cystic fibrosis: A global observational study.
Carr SB, McClenaghan E, Elbert A, Faro A, Cosgriff R, Abdrakhmanov O, Brownlee K, Burgel PR, Byrnes CA, Cheng SY, Colombo C, Corvol H, Daneau G, Goss CH, Gulmans V, Gutierrez H, Harutyunyan S, Helmick M, Jung A, Kashirskaya N, McKone E, Melo J, Middleton PG, Mondejar-Lopez P, de Monestrol I, Nährlich L, Padoan R, Parker M, Pastor-Vivero MD, Rizvi S, Ruseckaite R, Salvatore M, da Silva-Filho LVRF, Versmessen N, Zampoli M, Marshall BC, Stephenson AL; CF Registry Global Collaboration. Carr SB, et al. J Cyst Fibros. 2022 Jul;21(4):e221-e231. doi: 10.1016/j.jcf.2022.06.006. Epub 2022 Jun 13. J Cyst Fibros. 2022. PMID: 35753987 Free PMC article.
Cost-effectiveness of omalizumab for the treatment of severe pediatric allergic asthma-Results of a real-life study in Spain.
Nieto-Cid M, Garriga-Baraut T, Plaza-Martín AM, Tortajada-Girbés M, Torres-Borrego J, Lozano-Blasco J, Moreno-Galarraga L, Del Mar Folqué-Giménez M, Bosque-García M, Gaboli M, López-Neyra A, Rivas-Juesas C, Caballero-Rabasco MA, Freixa-Benavente A, Valdesoiro-Navarrete L, de Mir-Messa I, Ballester-Asensio E, Penín-Antón M, Romero-García R, Navarro-Morón J, Valenzuela-Soria A, Sánchez-Mateos M, Batlles-Garrido J, Sanz-Santiago V, de Atauri ÁG, Andrés-Martín A, Campos-Alonso E, Gómez-Pastrana D, Vázquez-Rodríguez E, Martínez-Pardo L, Del Río-Camacho G, Mazón-Ramos Á, Nieto-García A. Nieto-Cid M, et al. Among authors: lopez neyra a. Pediatr Allergy Immunol. 2023 Apr;34(4):e13942. doi: 10.1111/pai.13942. Pediatr Allergy Immunol. 2023. PMID: 37102393
Experience With Elexacaftor/Tezacaftor/Ivacaftor in Patients With Cystic Fibrosis and Advanced Disease.
Carrasco Hernández L, Girón Moreno RM, Balaguer Cartagena MN, Peláez A, Sole A, Álvarez Fernández A, Felipe Montiel A, Olveira C, Olveira G, Gómez Bonilla A, Gómez Crespo B, García Clemente M, Solís García M, Quaresma Vázquez J, Blitz Castro E, Rodríguez González J, Expósito Marrero A, Diab-Cáceres L, Ramos Hernández C, Zamarrón de Lucas E, Prados Sanchez C, Blanco Aparicio M, López Neyra A, Sanz Santiago V, Luna Paredes C, Delgado Pecellín I, Asensio de la Cruz Ó, Quintana Gallego E. Carrasco Hernández L, et al. Among authors: lopez neyra a. Arch Bronconeumol. 2023 Sep;59(9):556-565. doi: 10.1016/j.arbres.2023.05.017. Epub 2023 Jun 9. Arch Bronconeumol. 2023. PMID: 37400317 English, Spanish.
23 results